FindTrial
Sign In

Clinical Utility of Gadolinium Enhancement Magnetic Resonance Imaging for evaluation of Cardiac Events Risk in Confirmed Sarcoidosis: A Meta-Analysis

Clinical Utility of Gadolinium Enhancement Magnetic Resonance Imaging for evaluation of Cardiac Events Risk in Confirmed Sarcoidosis: A Meta-Analysis - Clinical Utility of Gadolinium Enhancement Magnetic Resonance Imaging for evaluation of Cardiac Events Risk in Confirmed Sarcoidosis: A Meta-Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000050688
Enrollment
Unknown
Registered
2023-03-27
Start date
2023-03-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Literature obtained by the following search formula will be considered. #1{Cardiac sarcoidosis OR sarcoidosis OR CS} #2{Late geranium enhancement OR LGE} #3{Magnetic resonance imaging OR MRI} #4 #1 AND #2 AND #3

Exclusion criteria

Exclusion criteria: References that are unsuitable for our analysis will be excluded.

Design outcomes

Primary

MeasureTime frame
Electronic database searches will be PubMed, Web of Science, Cochrane advanced search, and EMBASE. The risk is assessed using odds ratios of the occurrence of cardiovascular events against the presence or absence of delayed contrast in cases of confirmed or suspected cardiac sarcoidosis.—

Countries

Japan

Contacts

Public ContactRyusuke Sekii

Yokohama City University Medical Center Cardiovascular center

e113047e@yokohama-cu.ac.jp045-262-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026